RhumbLine Advisers’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580K | Buy |
297,486
+47,561
| +19% | +$92.7K | ﹤0.01% | 2595 |
|
|
2025
Q1 | $440K | Sell |
249,925
-13,880
| -5% | -$24.4K | ﹤0.01% | 2654 |
|
|
2024
Q4 | $702K | Sell |
263,805
-2,578
| -1% | -$6.86K | ﹤0.01% | 2453 |
|
|
2024
Q3 | $610K | Buy |
266,383
+5,444
| +2% | +$12.5K | ﹤0.01% | 2570 |
|
|
2024
Q2 | $762K | Buy |
260,939
+53,389
| +26% | +$156K | ﹤0.01% | 2394 |
|
|
2024
Q1 | $755K | Sell |
207,550
-2,747
| -1% | -$10K | ﹤0.01% | 2417 |
|
|
2023
Q4 | $318K | Sell |
210,297
-3,949
| -2% | -$5.96K | ﹤0.01% | 2935 |
|
|
2023
Q3 | $287K | Sell |
214,246
-185,963
| -46% | -$249K | ﹤0.01% | 2954 |
|
|
2023
Q2 | $720K | Buy |
400,209
+228,478
| +133% | +$411K | ﹤0.01% | 2468 |
|
|
2023
Q1 | $285K | Sell |
171,731
-2,598
| -1% | -$4.31K | ﹤0.01% | 2631 |
|
|
2022
Q4 | $335K | Buy |
174,329
+2,499
| +1% | +$4.8K | ﹤0.01% | 2635 |
|
|
2022
Q3 | $385K | Buy |
171,830
+9,431
| +6% | +$21.1K | ﹤0.01% | 2615 |
|
|
2022
Q2 | $526K | Sell |
162,399
-252
| -0.2% | -$816 | ﹤0.01% | 2478 |
|
|
2022
Q1 | $856K | Buy |
162,651
+12,174
| +8% | +$64.1K | ﹤0.01% | 2192 |
|
|
2021
Q4 | $1.28M | Buy |
150,477
+98,100
| +187% | +$834K | ﹤0.01% | 2107 |
|
|
2021
Q3 | $521K | Buy |
52,377
+17,730
| +51% | +$176K | ﹤0.01% | 2523 |
|
|
2021
Q2 | $323K | Buy |
+34,647
| New | +$323K | ﹤0.01% | 2758 |
|